Characterizing bathocuproine self-association and subsequent binding to Alzheimer's disease amyloid β-peptide by NMR

Journal of Peptide Science

Volumn 10, Issue 4, 2004, Pages 210-217

  Yao, Shenggen ^a   Cherny, Robert A ^b   Bush, Ashley I ^b,c   Masters, Colin L ^b   Barnham, Kevin J ^b  

^a Department of Civil and Environmental Engineering   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Bathocuproine; Ligand binding; NMR; Self association; Translational diffusion

Indexed keywords

AMYLOID BETA PROTEIN; BATHOCUPROINE 3,4 DISULFONIC ACID; CHELATING AGENT; CONGO RED; PHTHALOCYANINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CHEMICAL REACTION KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIMERIZATION; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; DRUG STRUCTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTON NUCLEAR MAGNETIC RESONANCE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; HUMANS; HYDROGEN; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE FRAGMENTS; PHENANTHROLINES;

EID: 1942454700     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.539     Document Type: Article

References (32)

1. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl Acad. Sci. USA 1985; 82: 4245-4249.
2. Huang X, Atwood CS, Moir RD, Hartshorn MA, Vonsattel JP, Tanzi RE, Bush AI. Zinc-induced Alzheimer's Aβ 1-40 aggregation is mediated by conformational factors. J. Biol. Chem. 1997; 272: 26 464-26 470.
3. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NME, Romano DM, Hartshorn MA, Tanzi RE, Bush AI. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 1998; 273: 12 817-12 826.
4. Martins PN, Harper CG, Stokes GB, Masters CL. Increased cerebral glucose-6-phosphate-dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem. 1986; 46: 1042-1045.
5. Multhaup G, Masters CL, Beyreuther K. Oxidative stress in Alzheimer's disease. Alzheimer's Rep. 2000; 1: 147-154.
6. Gabbita SP, Lovell MA, Markesbery WR. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 1998; 71: 2034-2040.
7. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 1997; 23: 134-147.
8. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, Huang X, Farrag YW, Perry G, Bush AI. Evidence that the β-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of Aβ by zinc. J. Biol. Chem. 2000; 275: 19 439-19 442.
9. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen-peroxide mediates amyloid-β protein toxicity. Cell 1994; 77: 817-827.
10. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC, Leopold M, Multhaup G, Goldstein LE, Scarpa RC, Saunders AJ, Lim J, Moir RD, Glabe C, Bowden EF, Masters CL, Fairlie DP, Tanzi RE, Bush AI. Cu(II) potentiation of Alzheimer Aβ neurotoxicity - correlation with cell-free hydrogen peroxide production and metal reduction. J. Biol. Chem. 1999; 274: 37 111-37 116.
11. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI. The Aβ peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999; 38: 7609-7616.
12. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998; 158: 47-52.
13. Smith MA, Harris PLR, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 1997; 94: 9866-9868.
14. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals. J. Neurochem. 2000; 74: 270-279.
15. Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, Beyreuther K, Tanzi RE, Masters CL, Bush AI. Aqueous dissolution of Alzheimer's disease Aβ amyloid deposits by biometal depletion. J. Biol. Chem. 1999; 274: 23 223-23 228.
16. Cherny RA, Barnham KJ, Lynch T, Volitakis I, Li QX, McLean CA, Multhaup G, Beyreuther K, Tanzi RE, Masters CL, Bush AI. Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease. J. Struct. Biol. 2000; 130: 209-216.
17. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI. Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 2001; 30: 665-676.
18. Martin RB. Comparisons of indefinite self-association models. Chem. Rev. 1996; 96: 3043-3064.
19. a) from solution NMR data. Tetrahedron 2000; 56: 6151-6170.
20. Curtain CC, Ali F, Volitakis I, Cherry RA, Norton RS, Beyreuther K, Barrow CJ, Masters CL, Bush AI, Barnham KJ. Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J. Biol. Chem. 2001; 276: 20 466-20 473.
21. Yao S, Howlett GJ, Norton RS. Peptide self-association in aqueous trifluoroethanol monitored by pulsed field gradient NMR diffusion measurements. J. Biomol. NMR 2000; 16: 109-119,
22. Piotto M, Saudek V, Sklenar V. Gradient tailored excitation for single quantum NMR spectroscopy of aqueous solutions. J. Biomol. NMR 1992; 2: 661-665.
23. Wishart DS, Bigam CG, Yao J, Abidgaard F, Dyson HJ, Oldfield E, Markley JL, Sykes BD. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR 1995; 6: 135-140.
24. Gibbs SJ, Johnson Jr CS. A PFG NMR experiment for accurate diffusion and flow studies in the presence of eddy currents. J. Magn. Reson. 1991; 93: 395-402.
25. Dingley AJ, Mackay JP, Chapman BE, Morris MB, Kuchel PW, Hambly BD, King GF. Measuring protein self-association using pulsed field gradient NMR spectroscopy: Application to myosin light chain 2. J. Biomol. NMR 1995; 6: 321-328.
26. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 1965; 42: 288-292.
27. Skowronek M, Stopa B, Konieczny L, Rybarska J, Piekarska B, Szneler E, Bakalarski G, Roterman I. Self-assembly of Congo red - a theoretical and experimental approach to identify its supramolecular organization in water and salt solutions. Biopolymers 1998; 46: 267-281.
28. Altieri AS, Hinton DP, Byrd PA. Association of biomolecular systems via pulsed field gradient NMR self-diffusion measurements. J. Am. Chem. Soc. 1995; 117: 7566-7567.
29. Pan H, Barany G, Woodward C. Reduced BPTI is collapsed. A pulsed field gradient NMR study of unfolded and partially folded bovine pancreatic trypsin inhibitor. Protein Sci. 1997; 6: 1985-1992.
30. Ilyina E, Roongta V, Pan H, Woodward C, Mayo KH. A pulsed-field gradient NMR study of bovine pancreatic trypsin inhibitor self-association. Biochemistry 1997; 36: 3383-3388.
31. Teller DC, Swanson E, de Haen C. The translational friction coefficient of proteins. Methods Enzymol. 1979; 61: 103-124.
32. Price WS, Tsuchiya F, Arata Y. Lysozyme aggregation and solution properties studied using PGSE NMR diffusion measurements. J. Am. Chem. Soc. 1999; 121: 11 503-11 512.